---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-245871"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:48:36.520979+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine prices upsized $250M offering; net proceeds ~$210.9M to fund bitopertin and extend cash runway into 2029

## Summary
- Net proceeds to Disc Medicine expected ~$210.9M; funds will support bitopertin commercialization for EPP/XLP, R&D, and general corporate purposes.
- Selling stockholder AI DMI LLC sold 297,619 shares at $84.00; underwriters exercised option to purchase additional 446,428 shares from AI DMI.
- Company expects cash, equivalents, and marketable securities plus offering net proceeds to fund operations into 2029, excluding potential bitopertin revenue.
- Pre-funded warrants have $0.0001 exercise price, immediate exercisability, and 24.99% ownership limit; not listed on Nasdaq.

## SEC filing metadata
- accession: 0001193125-25-245871
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312525245871/0001193125-25-245871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312525245871/d49689d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-245871
- JSON: https://secwatch.observer/filing/0001193125-25-245871.json
- Plain text: https://secwatch.observer/filing/0001193125-25-245871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.